Filing Details
- Accession Number:
- 0001104659-16-095142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-09 20:08:35
- Reporting Period:
- 2016-02-08
- Filing Date:
- 2016-02-09
- Accepted Time:
- 2016-02-09 20:08:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651308 | Beigene Ltd. | BGNE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1664990 | Ruirong Yuan | C/O Mourant Ozannes Corporate Services 94 Solaris Avenue Camana Bay E9 KY1-1108 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2016-02-08 | 130,000 | $1.85 | 130,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These ordinary shares are in the form of American Depositary Shares ("ADSs"). Each ADS represents 13 ordinary shares of the Issuer.
- These ordinary shares in the form of the ADSs were purchased through a directed share program in connection with the initial public offering of the Issuer.
- Calculated based on the initial public offering price of $24.00 per ADS divided by 13, the then ordinary share-to-ADS ratio.
Billionaire Hedge Funds
